US Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

US Clinical Nutrition for Diabetes Care Market Analysis

$ 3999

The US Clinical Nutrition for Diabetes Care Market was valued at $903 Mn in 2023 and is predicted to grow at a CAGR of 2.78% from 2023 to 2030, to $1094.08 Mn by 2030. The key drivers of this industry include increasing the prevalence of diabetes, advancements in nutritional science, and initiatives for diabetes management. The key players in the industry are Nestle Health Science, Perrigo Company PLC, Eli Lilly, and Baxter International Inc. among others.

ID: IN10USPH566 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Avantika Gupta

Buy Now

US Clinical Nutrition for Diabetes Care Market Executive Summary

The US Clinical Nutrition for Diabetes Care Market is at around $903.00 Mn in 2023 and is projected to reach $1094.08 Mn in 2030, exhibiting a CAGR of 2.78% during the forecast period.

Clinical nutrition for diabetes care refers to specialized dietary interventions and nutritional strategies designed to manage and improve the health outcomes of people with diabetes mellitus. It involves using evidence-based nutrition treatment to help diabetic patients maintain blood sugar control, avoid complications, and enhance their overall metabolic health. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes.

The increase in the prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is one of the factors contributing to the growth of the global clinical nutrition market. Obesity is a major factor leading to diabetes. Clinical nutrition including medical foods and parenteral nutrition can help relieve symptoms or slow down the progression of a chronic condition. As the number of people with diabetes continues to grow, so does the demand for these specialized food products. Patients afflicted with diabetes are at higher risk of comorbidities, as diabetes is a major cause of blindness, kidney failure, heart attacks, stroke, and lower limb amputation, as reported by the WHO.

The leading pharmaceutical companies Abbott Nutrition, and Nutricia North America are known for their extensive portfolio of medications, including those essential for diabetes care. Reckitt Benckiser Group PLC, Nestlé Health Science, and Perrigo Company PLC are also significant contributors to the Clinical Nutrition for Diabetes Care landscape, with continuous research and development activities.

US Clinical Nutrition for Diabetes Care Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Prevalence of Diabetes: The rising prevalence of diabetes in the US is a major factor driving the growth of the clinical nutrition market. The American Diabetes Association estimates that 38.4 Mn Americans, or 11.6% of the population, had diabetes in 2021. As the prevalence increases, so does the demand for effective diabetes management solutions.

Shift Towards Personalized Nutrition: There is an increasing focus on personalized nutrition in the US, with healthcare providers recognizing the importance of tailoring dietary recommendations to individual needs. This trend is driving the demand for clinical nutrition services that provide customized nutrition assessments and counseling for people with diabetes. These solutions aim to develop customized nutritional interventions based on an individual's genetic profile, disease state, and lifestyle factors, enabling more effective management of diabetes.

Advancements in Clinical Nutrition: Research in nutritional science is leading to the development of more targeted and effective clinical nutrition products for diabetic patients. This includes specialized formulas, personalized plans, and products catering to specific needs. Advances in nutritional science and technology are enabling the development of more personalized nutrition plans for people with diabetes. Some formulas may have a lower glycemic index, while others may be fortified with specific nutrients like chromium or magnesium that have been shown to improve insulin sensitivity.

Market Restraints

Access to Qualified Professionals: There is a lack of availability of registered dietitians, especially in rural or underserved communities, which is a major factor limiting the growth of clinical nutrition for the diabetes care market. Many people with diabetes lack access to the personalized nutrition assessments, counseling, and education provided by these healthcare professionals.

High Cost of Nutritional Counseling Services: The high cost of nutritional counseling services is another barrier that can limit access to clinical nutrition for diabetes care. If individuals with diabetes lack adequate health insurance coverage or financial resources to afford these out-of-pocket expenses, it becomes a significant restraint on market growth. Also, specialized clinical nutrition products like oral supplements and enteral feeding formulas can be expensive, creating a financial burden for patients.

Patient Compliance: In the US, following a diabetic meal plan and using specialized nutrition products is a hurdle. The taste of these products might not always be appealing, and making lifestyle changes like meal prepping or portion control takes effort. Social gatherings with tempting treats or family dinners that don't align with the plan add another layer of difficulty.

Regulatory Landscape and Reimbursement Scenario

Food and Drug Administration (FDA) is responsible for ensuring the safety and efficacy of all foods and medical foods in the US. This includes clinical nutrition products for diabetes care. Certain clinical nutrition products can be categorized as "medical foods." These are formulated for specific dietary needs related to a medical condition, but they are not considered drugs. Medical foods have some exemptions from FDA regulations regarding nutrient content and health claims.

The Centers for Medicare and Medicaid Services (CMS) provides reimbursement for medical nutrition therapy (MNT) and diabetes self-management training (DSMT) for Medicare beneficiaries. Reimbursement typically covers initial assessments, development of personalized nutrition plans, and follow-up consultations. Coverage may be limited in terms of frequency and duration. Coverage for specific clinical nutrition products like oral supplements or enteral feeding formulas can vary depending on the product, the patient's diagnosis, and the specific insurance plan.

Competitive Landscape

Key Players

Here are some of the major key players in the US Clinical Nutrition for Diabetes Care Market:

Abbott Nutrition
Nestlé Health Science
Novo Nordisk
Reckitt Benckiser Group PLC
Nutricia North America
Baxter International Inc.
Perrigo Company PLC
Omada Health
Vida Health
Eli Lilly

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

US Clinical Nutrition for Diabetes Care Market Segmentation

By Product

Oral Nutrition
Parenteral Nutrition
Enteral Feedback Formulas

By Stage

Adult
Paediatric

By Distribution Channel

Online
Retail
Institutional Sales

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.